-
Product Insights
Likelihood of Approval Analysis for Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD))
Overview How likely is it that the drugs in Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) Overview Adrenoleukodystrophy is a disorder that...
-
Product Insights
NewTriggering Receptor Expressed On Myeloid Cells 2 – Drugs In Development, 2024
The Triggering Receptor Expressed On Myeloid Cells 2 pipeline drugs market research report outlays comprehensive information on the Triggering Receptor Expressed On Myeloid Cells 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Oncology, Immunology, and Metabolic Disorders which include indications of Alzheimer's Disease, Dementia, Solid Tumor, Endometrial Cancer, Unspecified Immunological Disorders, Inflammation, and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Clazakizumab in End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Clazakizumab in End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Clazakizumab in End-Stage Kidney Disease...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Leriglitazone Hydrochloride in Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD))
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Leriglitazone Hydrochloride in Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) Drug Details: Leriglitazone hydrochloride is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Leriglitazone Hydrochloride in Friedreich Ataxia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Leriglitazone Hydrochloride in Friedreich Ataxia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Leriglitazone Hydrochloride in Friedreich Ataxia Drug Details: Leriglitazone hydrochloride is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PXL-770 in Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD))
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PXL-770 in Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) Drug Details: PXL-770 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CT-0594CP CAR-T Cells in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CT-0594CP CAR-T Cells in Refractory Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CT-0594CP CAR-T Cells in Refractory Multiple Myeloma Drug Details:...
-
Company Insights
Innovation and Patenting activity of ALD SA Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of ALD SA Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Sector Analysis
Car Rental Market Size, Share, Trends and Analysis by Customer Type, Location, Rental Sales by Channel and Segment Forecast to 2027
Accessing the in-depth insights from the ‘Car Rental Market’ report can help you: Analyze the car rental industry with a brief overview. Enhance the target audience's comprehension of the total addressable market (TAM), offering valuable insights into market potential. Identify the key regions witnessing the highest number of market dynamic activities such as mergers & acquisitions and venture financing. Provide insights into car rentals as per geographic region. Identify key market trends driving the growth of the market Anticipate changes in...